{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:42:27Z","timestamp":1793814147640,"version":"4.6.1"},"reference-count":20,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T00:00:00Z","timestamp":1699142400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"crossref","award":["2022-01608"],"award-info":[{"award-number":["2022-01608"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2023,10,9]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Many common neurological disorders are associated with advancing chronological age, but their association with biological age (BA) remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We studied 325\u2009870 participants in the UK Biobank without a diagnosed neurological condition at baseline and generated three previously-described measures of BA based on 18 routinely measured clinical biomarkers (PhenoAge, Klemera-Doubal method age (KDMAge), homeostatic dysregulation age). Using survival models, we assessed the effect of advanced BA on incident neurological diagnoses, including all-cause and cause-specific dementia, ischaemic stroke, Parkinson\u2019s disease and motor neuron disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>During a mean follow-up of 9.0 years, there were 1397 incident cases of dementia and 2515 of ischaemic stroke, with smaller case numbers of other diagnoses. The strongest associations with a 1 SD in BA residual were seen for all-cause dementia (KDMAge HR=1.19, 95% CI=1.11 to 1.26), vascular dementia (1.41, 1.25 to 1.60) and ischaemic stroke (1.39, 1.34 to 1.46). Weaker associations were seen for Alzheimer\u2019s disease and motor neuron disease, while, in contrast, HRs for Parkinson\u2019s disease tended to be &lt;1. Results were largely consistent after adjustment for disease-specific covariates including common cardiometabolic risk factors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Advanced BA calculated from routine clinical biomarker results increases the risk of subsequent neurological diagnoses including all-cause dementia and ischaemic stroke.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnnp-2023-331917","type":"journal-article","created":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T20:25:15Z","timestamp":1699215915000},"page":"481-484","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical biomarker-based biological ageing and future risk of neurological disorders in the UK Biobank"],"prefix":"10.1136","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4454-8580","authenticated-orcid":false,"given":"Jonathan K L","family":"Mak","sequence":"first","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher E","family":"McMurran","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"H\u00e4gg","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,11,5]]},"reference":[{"key":"2026081401350919000_95.5.481.1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ebiom.2017.03.046","article-title":"Biological age predictors","volume":"21","author":"Jylh\u00e4v\u00e4","year":"2017","journal-title":"EBioMedicine"},{"key":"2026081401350919000_95.5.481.2","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/gerona\/glab069","article-title":"A biomarker-based biological age in UK Biobank: composition and prediction of mortality and hospital admissions","volume":"76","author":"Chan","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026081401350919000_95.5.481.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02288-w"},{"key":"2026081401350919000_95.5.481.4","doi-asserted-by":"crossref","unstructured":"Gao X , Geng T , Jiang M , et al . Accelerated biological aging and risk of depression and anxiety: evidence from 424,299 UK Biobank participants. Nat Commun 2023;14. doi:10.1038\/s41467-023-38013-7","DOI":"10.1038\/s41467-023-38013-7"},{"key":"2026081401350919000_95.5.481.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95425-5","article-title":"Biological age in healthy elderly predicts aging-related diseases including dementia","volume":"11","author":"Wu","year":"2021","journal-title":"Sci Rep"},{"key":"2026081401350919000_95.5.481.6","doi-asserted-by":"crossref","unstructured":"McMurran CE , Wang Y , Mak JKL , et al . Advanced biological ageing predicts future risk for neurological diagnoses and clinical examination findings. Brain 2023:awad252. doi:10.1093\/brain\/awad252","DOI":"10.1093\/brain\/awad252"},{"key":"2026081401350919000_95.5.481.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLOS Med"},{"key":"2026081401350919000_95.5.481.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2005.10.004"},{"key":"2026081401350919000_95.5.481.9","doi-asserted-by":"crossref","first-page":"573","DOI":"10.18632\/aging.101414","article-title":"An epigenetic biomarker of aging for LifeSpan and Healthspan","volume":"10","author":"Levine","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"2026081401350919000_95.5.481.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2013.01.004"},{"key":"2026081401350919000_95.5.481.11","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30367-6"},{"key":"2026081401350919000_95.5.481.12","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1474-4422(18)30404-6","article-title":"Global, regional, and national burden of motor neuron diseases 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"17","author":"Logroscino","year":"2018","journal-title":"The Lancet Neurology"},{"key":"2026081401350919000_95.5.481.13","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23687"},{"key":"2026081401350919000_95.5.481.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60834-3"},{"key":"2026081401350919000_95.5.481.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2016.01.007"},{"key":"2026081401350919000_95.5.481.16","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/57.10.M660"},{"key":"2026081401350919000_95.5.481.17","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-006-0317-8"},{"key":"2026081401350919000_95.5.481.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173731","article-title":"Serum uric acid levels in patients with Parkinson\u2019s disease: A meta-analysis","volume":"12","author":"Wen","year":"2017","journal-title":"PLoS One"},{"key":"2026081401350919000_95.5.481.19","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00291","article-title":"Biomarkers in motor neuron disease: A state of the art review","volume":"10","author":"Verber","year":"2019","journal-title":"Front Neurol"},{"key":"2026081401350919000_95.5.481.20","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwx246"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2023-331917","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T09:37:11Z","timestamp":1786873031000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2023-331917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,5]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,4,12]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/jnnp-2023-331917"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2023-331917","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,5]]}}}